• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有致命性表面活性物质缺乏症的新生儿中的ABCA3基因突变。

ABCA3 gene mutations in newborns with fatal surfactant deficiency.

作者信息

Shulenin Sergey, Nogee Lawrence M, Annilo Tarmo, Wert Susan E, Whitsett Jeffrey A, Dean Michael

机构信息

Human Genetics Section, Laboratory of Genomic Diversity, National Cancer Institute - Frederick, Frederick, Md, USA.

出版信息

N Engl J Med. 2004 Mar 25;350(13):1296-303. doi: 10.1056/NEJMoa032178.

DOI:10.1056/NEJMoa032178
PMID:15044640
Abstract

BACKGROUND

Pulmonary surfactant forms a lipid-rich monolayer that coats the airways of the lung and is essential for proper inflation and function of the lung. Surfactant is produced by alveolar type II cells, stored intracellularly in organelles known as lamellar bodies, and secreted by exocytosis. The gene for ATP-binding cassette transporter A3 (ABCA3) is expressed in alveolar type II cells, and the protein is localized to lamellar bodies, suggesting that it has an important role in surfactant metabolism.

METHODS

We sequenced each of the coding exons of the ABCA3 gene in blood DNA from 21 racially and ethnically diverse infants with severe neonatal surfactant deficiency for which the etiologic process was unknown. Lung tissue from four patients was examined by high-resolution light and electron microscopy.

RESULTS

Nonsense and frameshift mutations, as well as mutations in highly conserved residues and in splice sites of the ABCA3 gene were identified in 16 of the 21 patients (76 percent). In five consanguineous families with mutations, each pair of siblings was homozygous for the same mutation and each mutation was found in only one family. Markedly abnormal lamellar bodies were observed by ultrastructural examination of lung tissue from four patients with different ABCA3 mutations, including nonsense, splice-site, and missense mutations.

CONCLUSIONS

Mutation of the ABCA3 gene causes fatal surfactant deficiency in newborns. ABCA3 is critical for the proper formation of lamellar bodies and surfactant function and may also be important for lung function in other pulmonary diseases. Since it is closely related to ABCA1 and ABCA4, proteins that transport phospholipids in macrophages and photoreceptor cells, it may have a role in surfactant phospholipid metabolism.

摘要

背景

肺表面活性物质形成一层富含脂质的单分子层,覆盖在肺气道表面,对肺的正常扩张和功能至关重要。表面活性物质由肺泡II型细胞产生,在细胞内储存于称为板层小体的细胞器中,并通过胞吐作用分泌。ATP结合盒转运体A3(ABCA3)基因在肺泡II型细胞中表达,其蛋白定位于板层小体,提示它在表面活性物质代谢中起重要作用。

方法

我们对21名患有严重新生儿表面活性物质缺乏且病因不明的种族和民族各异的婴儿的血液DNA中的ABCA3基因的每个编码外显子进行了测序。对4名患者的肺组织进行了高分辨率光镜和电镜检查。

结果

在21名患者中的16名(76%)中鉴定出ABCA3基因的无义突变、移码突变以及高度保守残基和剪接位点的突变。在5个有突变的近亲家庭中,每对兄弟姐妹对相同突变都是纯合的,且每个突变仅在一个家庭中发现。对4名具有不同ABCA3突变(包括无义突变、剪接位点突变和错义突变)的患者的肺组织进行超微结构检查,观察到明显异常的板层小体。

结论

ABCA3基因突变导致新生儿致命的表面活性物质缺乏。ABCA3对板层小体的正常形成和表面活性物质功能至关重要,在其他肺部疾病的肺功能中可能也很重要。由于它与ABCA1和ABCA4密切相关,这两种蛋白在巨噬细胞和光感受器细胞中转运磷脂,它可能在表面活性物质磷脂代谢中起作用。

相似文献

1
ABCA3 gene mutations in newborns with fatal surfactant deficiency.患有致命性表面活性物质缺乏症的新生儿中的ABCA3基因突变。
N Engl J Med. 2004 Mar 25;350(13):1296-303. doi: 10.1056/NEJMoa032178.
2
Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency.足月遗传性ABCA3缺乏婴儿肺表面活性物质系统的改变。
Am J Respir Crit Care Med. 2006 Sep 1;174(5):571-80. doi: 10.1164/rccm.200509-1535OC. Epub 2006 May 25.
3
Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation.由一种新型ABCA3突变引起的致命性新生儿间质性肺炎的超微结构和分子分析
Mod Pathol. 2007 Oct;20(10):1009-18. doi: 10.1038/modpathol.3800928. Epub 2007 Jul 27.
4
Ultrastructure of lamellar bodies in congenital surfactant deficiency.先天性表面活性物质缺乏时板层小体的超微结构
Ultrastruct Pathol. 2005 Nov-Dec;29(6):503-9. doi: 10.1080/01913120500323480.
5
Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review.婴幼儿和儿童遗传性弥漫性肺疾病的超微结构特征:一项队列研究及综述
Ultrastruct Pathol. 2013 Oct;37(5):356-65. doi: 10.3109/01913123.2013.811454.
6
Surfactant deficiency syndrome in an infant with a C-terminal frame shift in ABCA3: A case report.ABCA3 基因 C 末端移码突变致婴儿表面活性物质缺乏综合征 1 例报告
Pediatr Pulmonol. 2018 May;53(5):E12-E14. doi: 10.1002/ppul.23994. Epub 2018 Mar 22.
7
Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice.肺泡 II 型细胞中 Abca3 的条件性缺失改变了新生和成年小鼠的表面活性物质动态平衡。
Am J Physiol Lung Cell Mol Physiol. 2010 May;298(5):L646-59. doi: 10.1152/ajplung.00409.2009. Epub 2010 Feb 26.
8
Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency.致命性表面活性剂缺乏中ATP结合盒转运体ABCA3突变体的特征与分类
J Biol Chem. 2006 Nov 10;281(45):34503-14. doi: 10.1074/jbc.M600071200. Epub 2006 Sep 7.
9
[Detection of genetic defect within ABCA3 from newborns with respiratory distress syndrome].[对患有呼吸窘迫综合征新生儿ABCA3基因缺陷的检测]
Zhonghua Er Ke Za Zhi. 2012 Feb;50(2):111-6.
10
Expression of ABCA3, a causative gene for fatal surfactant deficiency, is up-regulated by glucocorticoids in lung alveolar type II cells.ABCA3是导致致命性表面活性剂缺乏的致病基因,其在肺II型肺泡细胞中的表达受糖皮质激素上调。
Biochem Biophys Res Commun. 2004 Oct 15;323(2):547-55. doi: 10.1016/j.bbrc.2004.08.133.

引用本文的文献

1
Lentiviral-mediated gene complementation rescues pathogenic variants.慢病毒介导的基因互补可挽救致病变体。
bioRxiv. 2025 Aug 30:2025.08.29.673150. doi: 10.1101/2025.08.29.673150.
2
THERAPIES FOR NEONATAL DISEASES OF THE SURFACTANT SYSTEM.用于治疗新生儿表面活性物质系统疾病的疗法。
Trans Am Clin Climatol Assoc. 2025;135:119-129.
3
Protein profiling in intensive care unit-treated COVID-19 patients identifies biomarkers of residual lung abnormalities.重症监护病房治疗的新冠肺炎患者的蛋白质谱分析确定了残留肺部异常的生物标志物。
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.00981-2024. eCollection 2025 May.
4
Novel Compound Heterozygous Mutation of the Gene in a Patient with Neonatal-Onset Interstitial Lung Disease.一名新生儿期起病的间质性肺疾病患者中该基因的新型复合杂合突变
J Clin Med. 2025 May 25;14(11):3704. doi: 10.3390/jcm14113704.
5
Alveolar epithelial paxillin in postnatal lung alveolar development.出生后肺肺泡发育中的肺泡上皮桩蛋白
Biol Open. 2025 Mar 15;14(3). doi: 10.1242/bio.061939. Epub 2025 Mar 20.
6
PBAE-PEG-based lipid nanoparticles for lung cell-specific gene delivery.基于聚(β-氨基酯)-聚乙二醇的脂质纳米颗粒用于肺细胞特异性基因递送。
Mol Ther. 2025 Mar 5;33(3):1154-1165. doi: 10.1016/j.ymthe.2025.01.037. Epub 2025 Jan 25.
7
A Protein with Unknown Function, Ps495620, Is Critical for the Sporulation and Oospore Production of .一种功能未知的蛋白质Ps495620对……的孢子形成和卵孢子产生至关重要。
J Fungi (Basel). 2024 Dec 27;11(1):12. doi: 10.3390/jof11010012.
8
c.838C>T (p.Arg280Cys, R280C) and c.697C>T (p.Gln233Ter, Q233X, Q233*) as Causative Variants for RDS: A Family Case Study and Literature Review.c.838C>T(p.Arg280Cys,R280C)和c.697C>T(p.Gln233Ter,Q233X,Q233*)作为呼吸窘迫综合征的致病变异:一项家系病例研究及文献综述
Biomedicines. 2024 Oct 18;12(10):2390. doi: 10.3390/biomedicines12102390.
9
Genome-wide DNA methylation profiling in blood reveals epigenetic signature of incident acute coronary syndrome.全基因组 DNA 甲基化谱在血液中揭示了急性冠状动脉综合征发病的表观遗传特征。
Nat Commun. 2024 Aug 28;15(1):7431. doi: 10.1038/s41467-024-51751-6.
10
Innovations in Childhood Interstitial and Diffuse Lung Disease.儿童间质性和弥漫性肺病的创新。
Clin Chest Med. 2024 Sep;45(3):695-715. doi: 10.1016/j.ccm.2024.04.002.